High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution

Treatment with high-dose melphalan chemotherapy supported by hematopoietic rescue with autologous stem cells produces high rates of hematologic responses and improvement in survival and organ function for patients with AL amyloidosis. Ongoing clinical trials explore pre-transplant induction regimens...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Amyloid
Hauptverfasser: Seldin, D. C., Andrea, N., Berenbaum, I., Berk, J. L., Connors, L., Dember, L. M., Doros, G., Fennessey, S., Finn, K., Girnius, S., Lerner, A., Libbey, C., Meier-Ewert, H. K., O’Connell, R., O’Hara, C., Quillen, K., Ruberg, F. L., Sam, F., Segal, A., Shelton, A., Skinner, M., Sloan, J. M., Wiesman, J. F., Sanchorawala, V.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5601311/
https://ncbi.nlm.nih.gov/pubmed/21838459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/13506129.2011.574354047
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge